Maui Derm

Other Key Congresses

January 25-29, 2026, Grand Wailea, Maui, Hawaii
Poster icon

Remibrutinib improves urticaria symptoms, quality of life, and sleep: An analysis from REMIX-1/-2 studies

Mark Lebwohl, Vipul Jain, Michihiro Hide, Hao Cheng, Petra Staubach-Renz, Sibylle Haemmerle, Christine Elke Ortmann, El-Djouher Martzloff, Karine Lheritier, Hugh Windom
Poster
Poster icon

Early and sustained efficacy of remibrutinib in adult patients with CSU: Pooled analysis of REMIX-1/-2 studies

Shaila Gogate, Michael Palumbo, Ana Maria Giménez-Arnau, Shiqin Tao, Michihiro Hide, Karine Lheritier, Paula Machado, Knut Brockow
Poster
Poster icon

Concomitant use of antiplatelet agents with remibrutinib in the Phase 3 REMIX-1/-2 studies

Lindsey Finklea, Michael Palumbo, Alis Burciu, Sibylle Haemmerle
Poster
January 20-24, 2025, Maui, Hawaii
Poster icon

Pooled REMIX-1/-2 phase 3 data: Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria

S. Saini, G. Mosnaim, A.G-Arnau, L. Li, El-D. Martzloff, A. Burciu, K. Lheritier, M. Metz

ePoster
March 27-31, 2026, Denver, Colorado, USA
Poster icon

A pooled analysis of the hemostatic safety profile of remibrutinib over 24 weeks in patients with chronic spontaneous urticaria from the REMIX-1 and REMIX-2 phase 3 studies

Mark Lebwohl, Sarbjit Saini, Michihiro Hide, Frederic Berard, Linfeng Li, Elodie Incera, Hichem Zouater, Karine Lheritier, Artem Zharkov, Knut Brockow
ePoster With Oral Presentation
Poster icon

Early symptom improvement with remibrutinib in chronic spontaneous urticaria: Daily itch severity scores and hives severity scores from phase 3 REMIX-1/-2 studies

Giselle Mosnaim, Petra Staubach, Bin Yang, Atsushi Fukunaga, El-Djouher Martzloff, Nadine Chapman-Rothe, Tao Ding, Gordon Sussman, Ana Maria Giménez-Arnau
ePoster With Oral Presentation
Poster icon

Specific autoantibodies may contribute to chronic spontaneous urticaria in a BTK-dependent manner

Martin Metz, Sarbjit Saini, Michihiro Hide, Theodoulos Rodosthenous, Alexandre Avrameas, Annika Loredana Kilian, Petra Budde, Hans-Dieter Zucht, Ulf Gehrmann, Nadine Chapman-Rothe, Sibylle Haemmerle
ePoster
Poster icon

Urticaria Voices: Treatment patterns and disease control in patients with self-reported chronic inducible urticaria

Giselle Mosnaim, Sabine Altrichter, Karsten Weller, Tonya A. Winders, Jessica McCarthy, Pallavi Saraswat, Nadine Chapman-Rothe, Tara Raftery, Jonathan A. Bernstein
ePoster
Poster icon

Out-of-pocket expenses in patients with chronic inducible urticaria (CIndU): Results from Urticaria Voices study

Tonya A. Winders, Jonathan A. Bernstein, Giselle Mosnaim, Tara Raftery, Nadine Chapman-Rothe, Jessica McCarthy, Panagiotis Orfanos, Ravneet Kaur Kohli, Dhaval Patil, Karsten Weller, Sabine Altrichter
ePoster
Poster icon

Design of the REASSERT Study: A prospective, multi-country, noninterventional effectiveness and safety study evaluating remibrutinib in patients worldwide with chronic spontaneous urticaria (CSU)

April W. Armstrong, Sarbjit Saini, Martin Metz, Zuotao Zhao, Tara Raftery, Nadine Chapman-Rothe, Iftekhar Khan, Dhaval Patil, Ana M. Giménez-Arnau
ePoster
Poster icon

Patients with chronic spontaneous urticaria (CSU) in the United States (US): Health care and economic burden associated with corticosteroid use

Gil Yosipovitch, Dhaval Patil, Jonathan Rodrigues, Merin Kuruvilla, Jason Doran, Irina Pivneva, Frédéric Kinkead, Panagiotis Orfanos, Tara Raftery, Marc A. Riedl
ePoster
Poster icon

Out-of-pocket expenses in patients with chronic spontaneous urticaria: Results from Urticaria Voices

T.A. Winders, J.A. Bernstein, T. Raftery, N.C-Rothe, J. McCarthy, P. Saraswat, P. Orfanos, R.K. Kohli, D. Patil, K. Weller
ePoster
Poster icon

Effect of remibrutinib on sleep and daily activities in patients with chronic spontaneous urticaria (CSU) up to week 52 in the REMIX-1/-2 studies

R. Snyder, Y. Bin, D. Merritt, S.F. Thomsen, A. Fukunaga, C. Field, S. Haemmerle, C-Ya. Chu, N. Seko, M. Metz
ePoster
Poster icon

Improvements in itch and hive symptoms with remibrutinib as early as week 1 in patients with chronic spontaneous urticaria (CSU) in REMIX-1/-2

M. Scarupa, S. Dinehart, X. Jiang, L. Finklea, J. Reed, Y.M. Ye, C. Field, S. Haemmerle, P. Wang, G. Sussman
ePoster
Poster icon

Effects of remibrutinib treatment on ambulatory blood pressure in adult patients with chronic spontaneous urticaria (CSU)

M. Palumbo, G. Mosnaim, U. Lippert, S. Haemmerle, M.F. Eigenmann, K. Lheritier, A. Zharkov, P. Machado, I. Rodriguez, M.G. Lebwohl
ePoster
Novartis logo
Cookie Settings
© Copyright 2026 Novartis Pharma AG